mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have raised concerns about resistance to neutralizing antibodies elicited by previous infection or vaccination. We examined whether sera from recovered and naïve donors, collected before and after immunizations with exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamatatos, Leonidas, Czartoski, Julie, Wan, Yu-Hsin, Homad, Leah J., Rubin, Vanessa, Glantz, Hayley, Neradilek, Moni, Seydoux, Emilie, Jennewein, Madeleine F., MacCamy, Anna J., Feng, Junli, Mize, Gregory, De Rosa, Stephen C., Finzi, Andrés, Lemos, Maria P., Cohen, Kristen W., Moodie, Zoe, McElrath, M. Juliana, McGuire, Andrew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139425/
https://www.ncbi.nlm.nih.gov/pubmed/33766944
http://dx.doi.org/10.1126/science.abg9175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139425/
https://www.ncbi.nlm.nih.gov/pubmed/33766944
http://dx.doi.org/10.1126/science.abg9175

Ejemplares similares